Breast Cancer: Diagnosis and Staging

Breast Cancer: Diagnosis and Staging

Breast Cancer: Diagnosis and Staging

On this page

Breast Cancer: Risks & Alerts - Spotting Trouble Early

  • Major Risk Factors:
    • Non-Modifiable:
      • Age (↑ risk >50 yrs), Female sex
      • Family Hx (1st degree), BRCA1/BRCA2 mutations
      • Personal Hx of breast Ca, LCIS, ADH
      • Early menarche (<12 yrs), Late menopause (>55 yrs)
      • Dense breast tissue
    • Modifiable:
      • Nulliparity or late first child (>30 yrs)
      • No breastfeeding
      • Combined HRT, OCPs (slight risk)
      • Obesity (postmenopausal), Alcohol, Radiation exposure
  • Clinical Alerts (Symptoms):
    • Painless lump (most common presentation)
    • Nipple changes: inversion/retraction, spontaneous bloody/serous discharge, Paget’s disease (eczematous changes)
    • Skin changes: dimpling (peau d’orange), tethering, erythema, ulceration
    • Axillary or supraclavicular lymphadenopathy
    • Breast asymmetry, contour changes, persistent pain (less common)

⭐ Most common site of breast cancer: Upper Outer Quadrant (UOQ).

Breast Cancer: Detective Work - Confirming Suspicions

  • Screening Methods:
    • Mammography: Annually for women aged >40-45 years (guidelines vary).
    • Clinical Breast Exam (CBE): Part of routine check-ups.
    • Breast Self-Exam (BSE): Promotes awareness.
  • Diagnostic Pathway:

    ⭐ Triple Assessment (Clinical exam, Imaging, Pathology/Biopsy) is key for diagnosis of palpable breast lumps.

Loading diagram…
*   **Imaging Insights**:
    *   Mammography: Detects masses, architectural distortion, microcalcifications. BI-RADS score guides management.
    *   Ultrasound: Differentiates solid vs. cystic lesions; primary tool <**35** yrs; guides biopsy.
    *   MRI: High-risk screening; assesses extent, multifocality, response to neoadjuvant chemotherapy.
*   **Pathology Confirmation**:
    *   Core Needle Biopsy (CNB): **Gold standard** for diagnosis. Provides tissue for histology, grade, and receptor status (ER, PR, HER2).
    *   FNAC: Limited; cannot assess invasiveness.
  • Staging: Based on TNM classification (Tumor size, Nodal status, Metastasis).

Breast Cancer: Lab Deep Dive - Types & Traits

  • Histopathology (Biopsy):
    • Invasive Ductal Carcinoma (IDC) NOS: Most common (~75%). Gritty, stellate appearance.
    • Invasive Lobular Carcinoma (ILC): ~10-15%. "Indian file" pattern (single cells in rows), often multifocal/bilateral.
    • Others: Tubular, Mucinous (Colloid), Medullary, Papillary.
  • Key Receptors & Markers (IHC Panel):
    • Estrogen Receptor (ER)
    • Progesterone Receptor (PR)
    • HER2/neu (Human Epidermal growth factor Receptor 2)
    • Ki-67 (Proliferation index)
  • Molecular Subtypes (Prognostic & Predictive):
    • Luminal A: ER+/PR+, HER2-, Low Ki-67. Best prognosis.
    • Luminal B: ER+/PR+, HER2+ OR (HER2- & High Ki-67).
    • HER2 Enriched: ER-/PR-, HER2+.
    • Basal-like (TNBC): ER-/PR-, HER2-.

⭐ Triple-negative breast cancer (TNBC) - ER negative, PR negative, HER2 negative - generally has the poorest prognosis among common subtypes.

Breast Cancer: Staging Showdown - Sizing Up the Foe

  • TNM System (AJCC 8th Ed.): Key for prognosis & therapy.
    • T (Tumor Size):
      • Tis: In situ
      • T1: ≤ 2 cm (T1mi ≤ 0.1 cm; T1a >0.1-0.5 cm; T1b >0.5-1 cm; T1c >1-2 cm)
      • T2: > 2 cm - ≤ 5 cm
      • T3: > 5 cm
      • T4: Chest wall/skin invasion; inflammatory (T4d)
    • N (Nodes):
      • N0: No regional LN
      • N1: Mobile ipsilateral axillary
      • N2: Fixed axillary OR isolated internal mammary (clinically apparent)
      • N3: Infraclavicular/supraclavicular/internal mammary + axillary
    • M (Metastasis):
      • M0: No distant
      • M1: Distant
  • Staging Types: Clinical (cTNM), Pathological (pTNM).

⭐ Axillary lymph node status is the single most important prognostic factor in early-stage, operable breast cancer.

High‑Yield Points - ⚡ Biggest Takeaways

  • Triple assessment (clinical exam, imaging, pathology) is vital for diagnosis.
  • Mammography is key for screening (>40 yrs); USG for younger or dense breasts.
  • MRI aids high-risk screening, staging, and assessing NACT response.
  • Core needle biopsy is the gold standard for definitive histological diagnosis.
  • Staging uses the TNM system; pathological staging is most accurate.
  • ER, PR, and HER2/neu status are crucial for prognosis and guiding therapy.
  • Axillary lymph node status remains the single most important prognostic factor.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Breast Cancer: Diagnosis and Staging

  1. 1. You are shown the screening mammogram of a 55-year-old woman. Which one of the following is the MOST likely diagnosis?

    • A. Fibroadenoma
    • B. Hematoma
    • C. Hamartoma
    • D. Galactocele
    • E. Oil cyst/Fat necrosis
    Show answer

    Answer: E. Oil cyst/Fat necrosis

    Oil cyst/Fat necrosis - Fat necrosis can form an oil cyst, a benign encapsulated collection of liquefied fat that appears as a round or oval radiolucent lesion. - A thin, well-defined rim, sometimes calcified over time, is characteristic; fat necrosis may follow trauma, surgery, radiation, or biopsy, or occur spontaneously. Fibroadenoma - Fibroadenoma is a benign fibrous and glandular tumor, most common in younger women, making it less likely in a 55-year-old woman. - Mammography usually shows a well-circumscribed, uniform-density mass, sometimes with coarse calcifications, rather than a radiolucent fatty lesion. Hematoma - Hematoma represents blood within breast tissue and is usually associated with trauma, biopsy, or surgery. - It more often appears as an increased-density or ill-defined mass with possible architectural distortion, unlike the characteristic radiolucent oil cyst. Galactocele - Galactocele is a milk-filled cyst that typically occurs during lactation or shortly after breastfeeding, which is unlikely in this 55-year-old woman. - It may show a fat-fluid level or variable-density circumscribed mass, not the thin-rimmed radiolucent appearance described here. Hamartoma - Hamartoma is a benign mixture of glandular, adipose, and fibrous tissues, producing a characteristic heterogeneous mass. - Its mammographic breast-within-a-breast or slice-of-lemon appearance differs from the purely radiolucent lesion of an oil cyst.

  2. 2. Which of the following muscles does NOT contribute, through its overlying fascia or aponeurosis, to the usual anatomical bed of the breast?

    • A. Latissimus dorsi
    • B. Serratus anterior
    • C. External oblique
    • D. Pectoralis major
    Show answer

    Answer: A. Latissimus dorsi

    Latissimus dorsi does not contribute to the usual anatomical bed of the breast and is therefore the exception. Pectoralis major contributes through its covering fascia and forms the largest part of the bed. Serratus anterior contributes through its covering fascia laterally. External oblique contributes inferiorly through its aponeurosis.

  3. 3. Worldwide, in adults of both sexes combined, which cancer causes the greatest number of cancer deaths?

    • A. Prostate cancer
    • B. Lung cancer
    • C. Adult leukemia
    • D. Colorectal cancer
    Show answer

    Answer: B. Lung cancer

    Lung cancer Lung cancer is the leading cause of cancer death worldwide for both sexes combined in IARC GLOBOCAN 2022 estimates. This is a combined-sex mortality ranking, not a claim that lung cancer leads separately in women. - Breast cancer leads cancer mortality among women in current global estimates. - Its high mortality reflects its aggressive nature, frequent late diagnosis, and limited treatment options in advanced disease. Prostate cancer - Prostate cancer is common in men, but it generally progresses more slowly and has a relatively high survival rate compared with lung cancer. - Early detection through screening often permits successful treatment, making prostate cancer a less frequent cause of cancer-related death overall. Adult leukemia - Adult leukemia affects the blood and bone marrow, but it causes fewer cancer deaths overall than major solid tumors such as lung cancer. - Advances in chemotherapy, stem-cell transplantation, and targeted therapies have improved survival for many leukemia types. Colorectal cancer - Colorectal cancer is a significant cause of cancer mortality, but it ranks behind lung cancer in overall cancer deaths. - Screening colonoscopy can detect disease early and remove precancerous polyps, thereby reducing colorectal cancer mortality. Reference: IARC GLOBOCAN 2022, worldwide mortality by cancer site and sex.

  4. 4. Which reproductive history is associated with increased breast cancer risk?

    • A. Menarche at 16 years
    • B. Nulliparity
    • C. Menopause at 40 years
    • D. Multiparity
    Show answer

    Answer: B. Nulliparity

    Nulliparity is an established reproductive risk factor for breast cancer. Menarche at 16 years does not confer the increased risk associated with early menarche. Menopause at 40 years does not confer the increased risk associated with late menopause. Multiparity is generally associated with lower long-term breast-cancer risk, particularly when the first full-term pregnancy occurs early.

  5. 5. Trinucleotide repeat expansion causes all of the following conditions EXCEPT:

    • A. Huntington disease
    • B. Spinocerebellar ataxia type 1
    • C. Charcot-Marie-Tooth disease
    • D. Friedreich ataxia
    Show answer

    Answer: C. Charcot-Marie-Tooth disease

    Charcot-Marie-Tooth disease - Charcot-Marie-Tooth disease is most commonly associated with PMP22 duplication, especially in CMT1A. - Because its common molecular causes include gene duplications, deletions, and point mutations rather than trinucleotide repeat expansions, it is the exception. Huntington disease - Huntington disease is caused by a pathogenic CAG trinucleotide repeat expansion in the HTT gene on chromosome 4. - This autosomal dominant neurodegenerative disorder demonstrates anticipation, making it a classic trinucleotide repeat disease rather than the exception. Spinocerebellar ataxia type 1 - Spinocerebellar ataxia type 1 is caused by a CAG trinucleotide repeat expansion. - This disorder produces progressive cerebellar ataxia and can demonstrate anticipation, supporting its inclusion among repeat-expansion diseases. Friedreich ataxia - Friedreich ataxia results from a GAA trinucleotide repeat expansion in the intronic region of the FXN gene on chromosome 9. - The expansion reduces frataxin expression and causes an autosomal recessive neurodegenerative disorder, so this option fits the repeat-expansion category.

  6. 6. Which one of the following is the primary defect in Pierre Robin syndrome?

    • A. High arched palate
    • B. Micrognathia
    • C. Cleft palate
    • D. Glossoptosis
    Show answer

    Answer: B. Micrognathia

    Micrognathia - Micrognathia, or an abnormally small mandible, is the primary defect in Pierre Robin sequence and occurs during mandibular development in early gestation. - The hypoplastic mandible provides insufficient space for the tongue, initiating the sequence of glossoptosis and secondary cleft palate formation. High arched palate - High-arched palate may occur in various craniofacial conditions, but it is not the defining primary abnormality of Pierre Robin sequence. - Pierre Robin sequence is identified by a developmental cascade rather than an isolated palatal shape: micrognathia leads to subsequent tongue displacement and palatal abnormality. Cleft palate - Cleft palate is a secondary or tertiary consequence, not the initiating defect, because the displaced tongue interferes with palatal shelf fusion. - Pierre Robin sequence classically produces a U-shaped cleft palate after glossoptosis develops as a consequence of mandibular hypoplasia. Glossoptosis - Glossoptosis, the posterior displacement of the tongue, is secondary to inadequate space created by the hypoplastic mandible. - Although glossoptosis can cause airway obstruction, it does not represent the primary developmental defect in Pierre Robin sequence.

  7. 7. What is the most reliable investigation to confirm carcinoma of the breast?

    • A. Breast mammography
    • B. Breast ultrasonography
    • C. Fine-needle aspiration cytology
    • D. Core biopsy
    Show answer

    Answer: D. Core biopsy

    Core biopsy - Histopathological examination directly evaluates tissue architecture and cellular characteristics, providing definitive confirmation of breast carcinoma. - A biopsy establishes malignancy and helps determine tumour type, grade, and receptor status, which are important for treatment planning. Breast mammography - Mammography can detect suspicious masses, calcifications, and architectural distortion, but these findings do not prove carcinoma. - Because it is an imaging investigation, mammography requires tissue sampling for definitive histological confirmation. Breast ultrasonography - Ultrasonography helps characterize breast lesions as solid or cystic and can identify suspicious features. - Although USG may guide a biopsy, it cannot definitively diagnose carcinoma without histological confirmation. Fine-needle aspiration cytology - FNAC examines individual cells and may suggest malignancy, but it does not provide the tissue architecture obtained by biopsy. - FNAC may produce false negatives and cannot reliably distinguish in situ from invasive carcinoma or assess tumour grade.

  8. 8. What is the investigation performed?

    • A. X-ray mammography
    • B. Breast MR imaging
    • C. Chest radiography
    • D. Breast ultrasonography
    Show answer

    Answer: A. X-ray mammography

    X-ray mammography - The paired compressed-breast projection radiographs are characteristic of mammography, which permits assessment of breast tissue, masses, and calcifications. - A dedicated breast X-ray unit uses compression paddles to spread tissue and improve visualization of masses and calcifications. Breast MR imaging - Breast MRI produces cross-sectional images in multiple planes, such as axial, sagittal, and coronal views, rather than compressed breast projections. - It commonly uses intravenous contrast to assess soft-tissue enhancement patterns, unlike the radiographic appearance shown here. Chest radiography - Plain chest radiography images the thoracic cavity, including the lungs, ribs, and mediastinum, usually in a standard chest projection. - It does not use specialized breast positioning and compression, which distinguish dedicated mammographic imaging from a chest X-ray. Breast ultrasonography - Breast ultrasonography produces sonographic sections using a transducer, rather than the compressed projection radiographs displayed here.

  9. 9. Which TN category describes lip carcinoma that has NOT spread to regional lymph nodes?

    • A. T2N2
    • B. T2N1
    • C. T3N0
    • D. T1N1
    Show answer

    Answer: C. T3N0

    T3N0 is correct because N0 denotes no regional lymph-node metastasis. T2N2 contains N2 and therefore indicates regional nodal metastasis. T2N1 and T1N1 both contain N1 and likewise indicate regional nodal metastasis. The T category does not change whether regional nodes are involved.

  10. 10. A 45-year-old lady presents with history of a painless lump in the right breast since 1 month. On examination, the lump is hard, 3 x 4 cm in size in the upper outer quadrant and is not fixed to the skin or the underlying structures. The axilla reveals firm mobile lymph nodes (level I). Rest of systemic examination is normal. The clinical stage of this disease is :

    • A. cT₃ N₁ Mₓ
    • B. cT₂ N₁ Mₓ
    • C. cT₁ N₁ Mₓ
    • D. cT₃ N₂ Mₓ
    Show answer

    Answer: B. cT₂ N₁ Mₓ

    cT₂ N₁ Mₓ - The 4 cm tumor is >2 cm but ≤5 cm, meeting the clinical T2 category; absence of skin or underlying fixation excludes locally advanced T4 disease. - Firm, mobile level I axillary nodes indicate regional N1 involvement. Distant metastasis has not been assessed clinically, so the designation is Mx. cT₃ N₂ Mₓ - T3 requires a tumor greater than 5 cm in its greatest dimension, whereas this lesion measures 4 cm at most and therefore fits T2. - Although Mx is appropriate, the mobile level I nodes represent N1 rather than N2; N2 generally involves fixed or matted axillary nodes or specified internal mammary-node disease. cT₃ N₁ Mₓ - This lesion does not meet T3 criteria because its greatest dimension is 4 cm, below the >5 cm threshold required for T3. - The N1 and Mx components fit the findings, but the incorrect T category makes the complete clinical stage unsuitable. cT₁ N₁ Mₓ - T1 applies to tumors measuring 2 cm or less in greatest dimension; this tumor measures 4 cm and therefore belongs in the T2 category. - The N1 and Mx components are consistent with the case, but the tumor size makes the T1 designation incorrect.

Flashcards: Breast Cancer: Diagnosis and Staging

  1. 1. According to the T category under AJCC classification of breast cancer, tumor size mm is T3

    Show answer

    >50

  2. 2. According to the T category under AJCC classification of breast cancer, inflammatory carcinoma is

    Show answer

    T4d

  3. 3. Is an excisional lymph node biopsy indicated for a palpable axillary lymph node in the presence of a suspicious breast mass?

    Show answer

    No

  4. 4. According to the T category under AJCC classification of breast cancer, tumor with chest wall invasion is

    Show answer

    T4a

  5. 5. Follow-up of patients after treatment of breast cancer consists of routine physical examination once in _____ months for a year and annual _____.

    Show answer

    3 · mammogram

  6. 6. N staging for Breast cancer: Metastasis to movable ipsilateral level I/II axillary nodes is _____, whereas fixed or matted nodes are _____.

    Show answer

    N1 · N2

  7. 7. Causes of bloody nipple discharge from a single duct: - _____ - _____ - _____

    Show answer

    Intraductal papilloma · Intraductal carcinoma · Duct ectasia

  8. 8. Winged scapula is commonly caused by:- _____ dissection after _____ - _____

    Show answer

    axillary node · mastectomy · stab wounds

  9. 9. Advanced invasive ductal carcinoma tumors may result in _____ of skin or _____ of the nipple

    Show answer

    dimpling · retraction

  10. 10. Discharges from the nipple (from a single duct or multiple ducts, any color): - _____ - _____ - _____

    Show answer

    Fibrocystic disease · Duct ectasia · Carcinoma

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF